Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physician's perspective

Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indications to existing drugs for lower costs compared to de novo drug development. Clinical rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayoumy, A. B., de Boer, N. K. H., Ansari, A. R., Crouwel, F., Mulder, C. J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366879/
https://www.ncbi.nlm.nih.gov/pubmed/32695427
http://dx.doi.org/10.1186/s40545-020-00249-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366879/
https://www.ncbi.nlm.nih.gov/pubmed/32695427
http://dx.doi.org/10.1186/s40545-020-00249-9

Ejemplares similares